This story was originally published on Food Dive. To receive daily news and insights, subscribe to our free daily Food Dive newsletter. Dive Brief: Yogurt giant Danone said Monday it reached an agreement to acquire a majority stake in Kate Farms, a maker of plant-based nutrition shakes. The acquisition will expand Danone’s specialized nutrition offerings. Kate Farms produces a variety of specialized shakes to support medical needs, daily nutritional goals, and kids’ health. Kate Farms’ senior management will retain a minority stake in the combined business following the close of the transaction, which is still subject to regulatory approval. No financial details were disclosed. Dive Insight: Though best known for its yogurts in the U.S., Danone has a wide portfolio of medical nutrition products that has recently garnered strong demand in other markets around the world. Now, Danone wants to replicate that success in North America by building out its offerings. Kate Farms was founded in 2012 by Richard and Michelle Laver, who wanted to create a better tasting alternative to tube feeding formulas for their daughter Kate, who has cerebral palsy. The products are sold to hospitals and consumers, and the brand entered a national retailer for the first time in March with a new children’s nutritional shake that will be sold at Target. “Kate Farms’ innovative medical nutrition products expand our offerings, enhance our ability to provide better solutions for people with wide-ranging health needs, and support healthier lives, both in the U.S. and globally,” Shane Grant, Danone Group Deputy CEO and CEO Americas, said in a statement. Danone’s specialized nutrition segment grew 5.3% in the first quarter compared to the same period last year. Recent product additions, including a plant-based tube feeding nutritional offering, “are growing very fast,” CFO Juergen Esser said in an earnings call last month, “getting us in a strong position to capture the growth this exciting category is offering.” The majority of Danone’s specialty nutrition products are in markets outside of North America, with executives noting that the company's U.S. business is heavily skewed toward yogurt and traditional dairy offerings. But with fast-paced growth of nutritional products, Esser said the company is “actively working to grow our other legs” of its North American business and expand its portfolio. While Kate Farms gives Danone more of a medical nutrition foothold in North America, the deal with the dairy giant also allows the U.S. brand to reach new markets. Story Continues “Together, we can bring our innovative scientifically developed nutritional products to more and more people,” Brett Matthews, CEO of Kate Farms, said in a statement. “Building on Danone’s expertise, we can also expand internationally.” Recommended Reading How Danone’s yogurt taps into consumer demand for ‘benefit stacking’ View Comments
Danone to buy majority stake in plant-based nutrition shake maker Kate Farms
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...